par Fisher, Charles J.;Opal, S.M.;Dhainaut, Jean-Francois;Stephens, S;Zimmerman, J L;Nightingale, P;Harris, S J;Schein, R M;Panacek, E A;Vincent, Jean Louis 
Référence Critical care medicine, 21, 3, page (318-327)
Publication Publié, 1993-03

Référence Critical care medicine, 21, 3, page (318-327)
Publication Publié, 1993-03
Article révisé par les pairs
| Titre: |
|
| Auteur: | Fisher, Charles J.; Opal, S.M.; Dhainaut, Jean-Francois; Stephens, S; Zimmerman, J L; Nightingale, P; Harris, S J; Schein, R M; Panacek, E A; Vincent, Jean Louis |
| Informations sur la publication: | Critical care medicine, 21, 3, page (318-327) |
| Statut de publication: | Publié, 1993-03 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| MeSH keywords: | Antibodies, Monoclonal -- therapeutic use |
| Bacteria -- isolation & purification | |
| Bacterial Physiological Phenomena | |
| Cytokines -- blood | |
| Female | |
| Humans | |
| Infection -- blood -- microbiology -- therapy | |
| Interleukin-6 -- blood | |
| Male | |
| Middle Aged | |
| Prospective Studies | |
| Shock, Septic -- blood -- microbiology -- therapy | |
| Tumor Necrosis Factor-alpha -- analysis -- biosynthesis -- immunology | |
| Note générale: | Clinical Trial |
| Clinical Trial, Phase II | |
| Controlled Clinical Trial | |
| Journal Article | |
| Multicenter Study | |
| Research Support, Non-U.S. Gov't | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0090-3493 |
| info:pmid/8440099 |



